血漿分画用コールドチェーン製品市場レポート：2030年までの動向、予測、競合分析

血漿分画用コールドチェーン製品の動向と予測

血漿分画用コールドチェーン製品の世界市場は、2024年から2030年までのCAGRが4.6%で、2030年までに推定7億米ドルに達すると予測されます。この市場の主な促進要因は、免疫グロブリンやその他の血漿製剤の使用量の増加、慢性疾患治療のための血漿ベースの医薬品に対するニーズの高まり、冷凍装置やシステムの継続的な進歩です。血漿分画用コールドチェーン製品の世界市場の将来は、採血センターおよび血液成分プロバイダー、病院・輸血センター、臨床研究ラボラトリーの各市場におけるビジネスチャンスにより有望視されています。

血漿分画用コールドチェーン製品市場の洞察

Lucintelは、温度モニタリング装置が予測期間中に最も高い成長を遂げると予測しています。

血友病や免疫不全疾患、肝疾患のような疾患の増加や高齢化人口の増加により、採血センター・血液成分プロバイダーが最大セグメントであり続けると予想されます。

北米は、血漿冷凍庫の需要が増加していること、および同地域の検査室向けに高度な保冷機器が利用可能であることから、予測期間中も最大セグメントであり続けると予想されます。

本レポートは以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 血漿分画用コールドチェーン製品の世界市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 血漿分画用コールドチェーン製品の世界市場の動向（2018～2023年）と予測（2024～2030年）
• タイプ別の血漿分画用コールドチェーン製品の世界市場
  • 超低温冷凍庫
  • プラズマ冷凍庫
  • 温度モニタリング装置
  • 血漿用コンタクトショックフリーザー
  • 血液輸送ボックス
  • アイスライニング式冷蔵庫
  • その他
• 最終用途別の血漿分画用コールドチェーン製品の世界市場
  • 採血センター・血液成分プロバイダー
  • 病院・輸血センター
  • CRO
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の血漿分画用コールドチェーン製品の世界市場
• 北米の血漿分画用コールドチェーン製品市場
• 欧州の血漿分画用コールドチェーン製品市場
• アジア太平洋の血漿分画用コールドチェーン製品市場
• その他地域の血漿分画用コールドチェーン製品市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の血漿分画用コールドチェーン製品の世界市場の成長機会
  • 最終用途別の血漿分画用コールドチェーン製品の世界市場の成長機会
  • 地域別の血漿分画用コールドチェーン製品の世界市場の成長機会
• 血漿分画用コールドチェーン製品の世界市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 血漿分画用コールドチェーン製品の世界市場の能力拡大
  • 血漿分画用コールドチェーン製品の世界市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• B Medical systems
• Blue Star
• Thermo Fisher Scientific
• Godrej and Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions

Cold Chain Products For Plasma Fractionation Trends and Forecast

The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets. The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

A more than 150-page report is developed to help in your business decisions.

Cold Chain Products For Plasma Fractionation by Segment

The study includes a forecast for the global cold chain products for plasma fractionation by type, end use, and region.

Cold Chain Products Market for Plasma Fractionation by Type [Shipment Analysis by Value from 2018 to 2030]:

• Ultra-low temperature freezer
• Plasma freezer
• Temperature monitoring devices
• Plasma contact shock freezer
• Blood transport boxes
• Ice-lined refrigerator
• Others

Cold Chain Products Market for Plasma Fractionation by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Blood collection centers and blood component providers
• Hospitals and transfusion centers
• Clinical research laboratories
• Others

Cold Chain Products Market for Plasma Fractionation by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cold Chain Products Companies for Plasma Fractionation

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cold chain products companies for plasma fractionation cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cold chain products for plasma fractionation companies profiled in this report include-

• B Medical Systems
• Blue Star
• Thermo Fisher Scientific
• Godrej And Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions

Cold Chain Products for Plasma Fractionation Market Insights

Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Blood collection center and blood component provider will remain the largest segment due to increasing number of diseases like hemophilia and immune deficiency disorders as well as liver diseases and rising aging population.

North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Features of the Global Cold Chain Products Market for Plasma Fractionation

Market Size Estimates: Cold chain products market for plasma fractionation size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cold chain products market for plasma fractionation size by type, end use, and region. in terms of value ($M).

Regional Analysis: Cold chain products market for plasma fractionation breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the cold chain products market for plasma fractionation.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cold chain products market for plasma fractionation.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the cold chain products market for plasma fractionation size?

Answer: The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030.

Q.2. What is the growth forecast for cold chain products market for plasma fractionation?

Answer: The global cold chain products market for plasma fractionation is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the cold chain products market for plasma fractionation?

Answer: The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

Q.4. What are the major segments for cold chain products market for plasma fractionation?

Answer: The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets.

Q.5. Who are the key cold chain products market for plasma fractionation companies?

Answer: Some of the key cold chain products for plasma fractionation companies are as follows:

• B Medical systems
• Blue Star
• Thermo Fisher Scientific
• Godrej and Boyce
• Haier Biomedical
• Eppendorf
• Avantor
• Biolife Solutions

Q.6. Which cold chain products market for plasma fractionation segment will be the largest in future?

Answer: Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Q.7. In cold chain products market for plasma fractionation, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cold chain products market for plasma fractionation by type (ultra-low temperature freezer, plasma freezer, temperature monitoring devices,plasma contact shock freezer, blood transport boxes, ice-lined refrigerator, and others), end use (blood collection centers and blood component providers, hospitals and transfusion centers, clinical research laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cold Chain Products Market for Plasma Fractionation: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cold Chain Products Market for Plasma Fractionation Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cold Chain Products Market for Plasma Fractionation by Type
  • 3.3.1: Ultra-low Temperature Freezer
  • 3.3.2: Plasma Freezer
  • 3.3.3: Temperature Monitoring Devices
  • 3.3.4: Plasma Contact Shock Freezer
  • 3.3.5: Blood Transport Boxes
  • 3.3.6: Ice-lined Refrigerator
  • 3.3.7: Others
• 3.4: Global Cold Chain Products Market for Plasma Fractionation by End Use
  • 3.4.1: Blood collection Centers and Blood Component Providers
  • 3.4.2: Hospitals and Transfusion Centers
  • 3.4.3: Clinical Research Laboratories
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cold Chain Products Market for Plasma Fractionation by Region
• 4.2: North American Cold Chain Products Market for Plasma Fractionation
  • 4.2.2: North American Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
• 4.3: European Cold Chain Products Market for Plasma Fractionation
  • 4.3.1: European Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
  • 4.3.2: European Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
• 4.4: APAC Cold Chain Products Market for Plasma Fractionation
  • 4.4.1: APAC Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
  • 4.4.2: APAC Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
• 4.5: ROW Cold Chain Products Market for Plasma Fractionation
  • 4.5.1: ROW Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
  • 4.5.2: ROW Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Type
  • 6.1.2: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by End Use
  • 6.1.3: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Region
• 6.2: Emerging Trends in the Global Cold Chain Products Market for Plasma Fractionation
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cold Chain Products Market for Plasma Fractionation
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cold Chain Products Market for Plasma Fractionation
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: B Medical systems
• 7.2: Blue Star
• 7.3: Thermo Fisher Scientific
• 7.4: Godrej and Boyce
• 7.5: Haier Biomedical
• 7.6: Eppendorf
• 7.7: Avantor
• 7.8: Biolife Solutions